305 related articles for article (PubMed ID: 34430370)
1. Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review.
Mentink JF; Paats MS; Dumoulin DW; Cornelissen R; Elbers JBW; Maat APWM; von der Thüsen JH; Dingemans AC
Transl Lung Cancer Res; 2021 Jul; 10(7):3329-3338. PubMed ID: 34430370
[TBL] [Abstract][Full Text] [Related]
2. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
[TBL] [Abstract][Full Text] [Related]
3. How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review.
Remon J; Menis J; Levy A; De Ruysscher DKM; Hendriks LEL
Transl Lung Cancer Res; 2021 Jul; 10(7):3486-3502. PubMed ID: 34430382
[TBL] [Abstract][Full Text] [Related]
4. The "new" oligometastatic disease state and associated therapies in non-small cell lung cancer: A narrative review.
Na KJ; Kim YT
J Surg Oncol; 2023 Feb; 127(2):282-287. PubMed ID: 36464990
[TBL] [Abstract][Full Text] [Related]
5. The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review.
Berzenji L; Debaenst S; Hendriks JMH; Yogeswaran SK; Lauwers P; Van Schil PE
Transl Lung Cancer Res; 2021 Jul; 10(7):3409-3419. PubMed ID: 34430376
[TBL] [Abstract][Full Text] [Related]
6. Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.
Giaj-Levra N; Giaj-Levra M; Durieux V; Novello S; Besse B; Hasan B; Hendriks LE; Levy A; Dingemans AC; Berghmans T;
J Thorac Oncol; 2019 Dec; 14(12):2053-2061. PubMed ID: 31195177
[TBL] [Abstract][Full Text] [Related]
7. The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer.
Euhus CJ; Ripley TR; Medina CG
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626125
[TBL] [Abstract][Full Text] [Related]
8. Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.
Rashdan S; Iyengar P; Minna JD; Gerber DE
Transl Lung Cancer Res; 2021 Jul; 10(7):3351-3368. PubMed ID: 34430372
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis.
Gobbini E; Bertolaccini L; Giaj-Levra N; Menis J; Giaj-Levra M
Transl Lung Cancer Res; 2021 Jul; 10(7):3339-3350. PubMed ID: 34430371
[TBL] [Abstract][Full Text] [Related]
10. Changing equipoise in the landscape of radiation for oligometastatic lung cancer.
Schroeder SR; Leenders M; Iyengar P; de Ruysscher D
Transl Lung Cancer Res; 2019 Sep; 8(Suppl 2):S184-S191. PubMed ID: 31673523
[TBL] [Abstract][Full Text] [Related]
11. Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
Dingemans AC; Hendriks LEL; Berghmans T; Levy A; Hasan B; Faivre-Finn C; Giaj-Levra M; Giaj-Levra N; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Smit EF; Van Schil P; Postmus PE; Ramella S; Lievens Y; Gaga M; Peled N; Scagliotti GV; Senan S; Paz-Ares L; Guckenberger M; McDonald F; Ekman S; Cufer T; Gietema H; Infante M; Dziadziuszko R; Peters S; Porta RR; Vansteenkiste J; Dooms C; de Ruysscher D; Besse B; Novello S
J Thorac Oncol; 2019 Dec; 14(12):2109-2119. PubMed ID: 31398540
[TBL] [Abstract][Full Text] [Related]
12. Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update.
Chen YH; Ho UC; Kuo LT
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267658
[TBL] [Abstract][Full Text] [Related]
13. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions.
Couñago F; Luna J; Guerrero LL; Vaquero B; Guillén-Sacoto MC; González-Merino T; Taboada B; Díaz V; Rubio-Viqueira B; Díaz-Gavela AA; Marcos FJ; Del Cerro E
World J Clin Oncol; 2019 Oct; 10(10):318-339. PubMed ID: 31799148
[TBL] [Abstract][Full Text] [Related]
14. The current state of oligometastatic and oligoprogressive non-small cell lung cancer.
Tumati V; Iyengar P
J Thorac Dis; 2018 Aug; 10(Suppl 21):S2537-S2544. PubMed ID: 30206497
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
16. Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?
Peeters STH; Van Limbergen EJ; Hendriks LEL; De Ruysscher D
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925139
[TBL] [Abstract][Full Text] [Related]
17. Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.
Gauvin C; Krishnan V; Kaci I; Tran-Thanh D; Bédard K; Albadine R; Leduc C; Gaboury L; Blais N; Tehfe M; Routy B; Florescu M
Curr Oncol; 2021 Jan; 28(1):593-605. PubMed ID: 33498159
[TBL] [Abstract][Full Text] [Related]
18. A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis.
Spaggiari L; Bertolaccini L; Facciolo F; Gallina FT; Rea F; Schiavon M; Margaritora S; Congedo MT; Lucchi M; Ceccarelli I; Alloisio M; Bottoni E; Negri G; Carretta A; Cardillo G; Ricciardi S; Ruffini E; Costardi L; Muriana G; Viggiano D; Rusca M; Ventura L; Marulli G; De Palma A; Rosso L; Mendogni P; Crisci R; De Vico A; Maniscalco P; Tamburini N; Puma F; Ceccarelli S; Voltolini L; Bongiolatti S; Morelli A; Londero F
Lung Cancer; 2021 Apr; 154():29-35. PubMed ID: 33610120
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
20. Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study.
Arrieta O; Barrón F; Maldonado F; Cabrera L; Corona-Cruz JF; Blake M; Ramírez-Tirado LA; Zatarain-Barrón ZL; Cardona AF; García O; Arén O; De la Garza J
Lung Cancer; 2019 Apr; 130():67-75. PubMed ID: 30885354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
